LCM
NKTR icon

Leisure Capital Management’s Nektar Therapeutics NKTR Stock Holding History

Leisure Capital Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-310
Closed -$283K – 135
2018
Q3 		$283K Sell
310
-33
-10% -$28.2K 0.23% 109
2018
Q2 		$251K Buy
343
+29
+9% +$33.4K 0.21% 116
2018
Q1 		$500K Sell
314
-325
-51% -$419K 0.44% 65
2017
Q4 		$572K Sell
639
-52
-8% -$30.8K 0.48% 61
2017
Q3 		$249K Sell
691
-13
-2% -$4.07K 0.22% 84
2017
Q2 		$206K Sell
704
-22
-3% -$6.36K 0.18% 95
2017
Q1 		$256K Sell
726
-295
-29% -$66.3K 0.23% 74
2016
Q4 		$188K Buy
1,021
+18
+2% +$3.66K 0.17% 93
2016
Q3 		$258K Sell
1,003
-7
-0.7% -$1.8K 0.24% 79
2016
Q2 		$216K Buy
1,010
+1
+0.1% +$224 0.21% 88
2016
Q1 		$208K Sell
1,009
-92
-8% -$17.7K 0.21% 88
2015
Q4 		$278K Buy
1,101
+25
+2% +$5.14K 0.25% 77
2015
Q3 		$177K Buy
1,076
+29
+3% +$5.13K 0.19% 83
2015
Q2 		$196K Buy
1,047
+147
+16% +$25.3K 0.19% 82
2015
Q1 		$148K Buy
900
+59
+7% +$12.1K 0.15% 87
2014
Q4 		$196K Buy
+841
New +$180K 0.19% 81

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Leisure Capital Management's NKTR Position: Q4 2018 in Review

Leisure Capital Management sold out of Nektar Therapeutics (NKTR) in Q4 2018, closing a stake of 310 shares — an estimated $283K sold.

Leisure Capital Management first reported a position in NKTR in Q4 2014 and held it in 16 quarters. The position peaked at $572K in Q4 2017. 342 funds tracked by Wall St. Rank hold NKTR as of Q4 2018.

  • Leisure Capital Management reported no remaining Nektar Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Leisure Capital Management sold 310 Nektar Therapeutics shares in Q4 2018, an estimated $283K.
  • Leisure Capital Management first reported a position in Nektar Therapeutics in Q4 2014 and held it in 16 quarters.
  • Leisure Capital Management's Nektar Therapeutics position peaked at $572K in Q4 2017.
  • 342 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2018.

Based on Leisure Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.